Cyclic withdrawal from endogenous and exogenous progesterone increases kainic acid and perforant pathway induced seizures

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 315-321

  Frye, Cheryl A ^a,b   Bayon, Laura E ^a  

^a The Holleran Center for Community Action and Public Policy   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Antiseizure; Extragenomic; Hippocampus; Neuroprotection; Neurosteroid; Progesterone 5 pregnan 3 ol 20 one (3 ,5 THP)

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL BENZOATE; KAINIC ACID; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ESTRADIOL; ESTRUS; FEMALE; KAINIC ACID; OVARIECTOMY; PERFORANT PATHWAY; PROESTRUS; PROGESTERONE; RATS; RATS, LONG-EVANS; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; SESAMUM INDICUM;

EID: 0032934817     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00182-8     Document Type: Article

References (52)

1. Backstrom B, Zetterlund B., Blom S., Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand. 60:1984;240-248.
2. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54:1976;321-347.
3. Belelli D., Bolger M.B., Gee K.W. Anticonvulstant profile of the progesterone metabolite 5α-pregnan-3α,ol-20-one. Eur. J. Pharmacol. 166:1989;325-329.
4. Brinton R.D. The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J. Neurosci. 14:1994;2763-2774.
5. Buck K.J., McQuillen S.J., Harris R.A. Modulation of GABA receptor operated chloride channels by benzodiazepine inverse agonists is related to genetic differences in ethanol withdrawal seizure severity. J. Neurochem. 57:1991;2100-2105.
6. Butterbaugh G.C. Postictal events in amygdala-kindled female rats with and without estradiol placement. Exp. Neurol. 95:1987;697-713.
7. Calixto E. Montiel, T.; Lemini, C.; Brailowsky, S. Allopregnanolone potentiates a GABA-withdrawal syndrome in the rat cerebral cortex Neurosci. Lett. 195:1995;73-76.
8. Enna S.J., Bowery N.G. The GABA receptors. 1997;Humana Press, Totowa, NJ.
9. A receptor complex. J. Pharmacol. Exp. Ther. 265:1993;1374-1379.
10. Finn D.A., Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271:1994;164-170.
11. Finn D.A., Roberts A.J., Lotrich F., Gallagher E.J. Genetic differences in behavioral sensitivity to a neuroactive steroid. J. Pharmacol. Exp. Ther. 280:1997;820-828.
12. Frye C.A. The neurosteroid 3α,5α-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
13. Frye, C. A.; Bayon, L. E.: Increased seizure activity following precipitous decline in endogenous 3α,5α-THP. Neuroendocrinology 68:272-280; 1998.
14. Frye, C. A.; Bayon, L. E.; Pursnani, N. K.; Purdy, R. H.: Neurosteroids, P and 3α,5α-THP, enhance proceptivity, receptivity, and sexual motivation in female rates. Brain Res. 808:72-83; 1998.
15. Frye, C. A.; Scalise, T.: Anti-seizure effects of P and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology (submitted).
16. Frye C.A., Scalise T., Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrin. 10:1998;291-296.
17. - ionophore by steroids in rat brain. Eur. J. Pharmacol. 136:1987;419-423.
18. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., McEwen B.S. Steroid modulation of the chloride ionophore in rat brain. Structure-activity requirements, regional dependence and mechanism of action J. Pharmacol. Exp. Ther. 246:1988;803-812.
19. Hauser P., Devinsky O., DeBellis M., Theodore W.H., Post R.M. Benzodiazepine withdrawal delirium with catatonic features. Occurrences in patients with partial seizure disorders. Arch. Neurol. 46:1989;696-699.
20. Iswari S., Colas A.E., Karavolas H.J. Binding of 5α-dihydroprogesterone and other progestins to female rat anterior pituitary nuclear extracts. Steroids. 47:1986;189-203.
21. Laidlaw J. Catamenial epilepsy. Lancet. 2:1956;1235-1237.
22. A receptor. Trends Pharmacol. 8:1987;224-227.
23. Landgren S., Aasly J., Backstrom T., Dubrovsky B., Danielson E. The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol. Scand. 131:1987;33-42.
24. Locock C. Discussion of paper by E. H. Sieveking: Analysis of. 52(cases of epilepsy observed by the author. Lancet 1):1857;528.
25. Luine V.N., Grattan D.R., Selmanoff M. Gonadal hormones alter hypothalamic GABA and glutamate levels. Brain Res. 747:1997;165-168.
26. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
27. Mattson, R. H.; Cramer, J. A.: Epilepsy, sex hormones and antiepileptic drugs. Epilepsia 26:s40-s51; 1985.
28. McCaslin P.P., Morgan W.M. Anticonvulsant activity of several excitatory amino acids antagonists against barbital withdrawal-induced spontaneous convulsions. Eur. J. Pharmacol. 147:1988;381-386.
29. Morrow A.L., Suzdak P.D., Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur. J. Pharmacol. 142:1987;483-485.
30. A receptors. FASEB J. 4:1990;1469-1480.
31. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites. An evaluation using the burying behavior test Brain Res. 680:1995;135-141.
32. A receptor subunit composition? Recept. Channels. 1:1993;135-142.
33. Purdy R.H., Moore P.H., Narasimha Roa P., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., Paul S.M. Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids. 55:1990;290-296.
34. Robel P., Baulieu E.-E. Neurosteroids. Biosynthesis and function Trends Endocrinol. Metab. 5:1994;1-8.
35. Rodbard, D.; Hutt, D. M.: Statistical analysis of radioimmunoassay and immunoradiometric assays: A generalized, weighted iterative, least squares method for logistic curve fitting. In: International Atomic Energy Agency. Symposium on radioimmunoassay and related procedures in medicine. New York: Uniput; 1974.
36. Rosciszewska D., Buntner B., Guz I., Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J. Neurol. Neurosurg. Psychol. 49:1986;47-51.
37. A receptors in specific brain regions by ovarian hormones. Neuroendocrinology. 50:1989;315-320.
38. Schumacher M., Robel P., Baulieu E.E. Development and regeneration of the nervous system. A role for neurosteroids Dev. Neurosci. 18:1996;6-21.
39. A receptor-gated ion channel. Biochemical and pharmacological studies of structure and function Biochem. Pharmacol. 37:1988;3369-3375.
40. - uptake in rat brain synaptoneurosomes. Evidence for rapid desensitization of the GABA receptor-coupled chloride ion channel Mol. Pharmacol. 30:1986;419-426.
41. Selye H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J. Lab. Clin. Med. 2:1942;1051-1053.
42. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 392:1998;926-930.
43. A receptor α4 subunit in association with increased anxiety. J. Neurosci. 18:5275-5284; 1998.
44. Sutula, T. P.: Experimental models of temporal lobe epilepsy: New insights from the study of kindling and synaptic reorganization. Epilepsia 31:s45-s54; 1990.
45. Sutula T., Xiao-Xian H., Cavazos J., Scott G. Synaptic reorganization of the hippocampus induced by abnormal functional activity. Science. 239:1988;1147-1150.
46. A receptor stimulation during the estrous cycle of the rat. Br. J. Pharmacol. 103:1991;1580-1584.
47. Wilson M. Influences of gender, gonadectomy, and estrus cycle, on GABA/BZ receptors and benzodiazepine response in rats. Brain Res. Bull. 29:1992;165-172.
48. Wooley C., Gould E., Frankfurt M., McEwen B.S. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J. Neurosci. 10:1990;4035-4039.
49. Wooley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336:1994;293-306.
50. A response and its potentiation by modulators in cortical neurons. Brain Res. 706:1996;160-162.
51. A receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275:1995;784-789.
52. A/benzodiazepine receptor complex in mammalian cortical neurons. Mol. Pharmacol. 47:1995;603-610.